View Archive »
About The Cover
The cover for issue 24 of Oncotarget features Figure 1, "Workflow for enumeration of cleaved caspase-3 bleb−positive [CC3(bleb)+] cells in FFPE canine tumor tissue," from Dull, et al.
|
|
Table of Contents
Research Papers: Pathology
|
| A novel occludintargeting monoclonal antibody prevents hepatitis C virus infection in vitro |
|
https://doi.org/10.18632/oncotarget.24742
|
| 16588-16598 |
Research Papers
|
| Momelotinib decreased cancer stem cell associated tumor burden and prolonged diseasefree remission period in a mouse model of human ovarian cancer |
|
https://doi.org/10.18632/oncotarget.24615
|
| 16599-16618 |
|
| Improved therapy for medulloblastoma: targeting hedgehog and PI3KmTOR signaling pathways in combination with chemotherapy |
|
https://doi.org/10.18632/oncotarget.24618
|
| 16619-16633 |
|
| Esophageal squamous cell carcinoma transcriptome reveals the effect of FOXM1 on patient outcome through novel PIK3R3 mediated activation of PI3K signaling pathway |
|
https://doi.org/10.18632/oncotarget.24621
|
| 16634-16647 |
|
| ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer |
|
https://doi.org/10.18632/oncotarget.24625
|
| 16648-16664 |
|
| High CTLA4 expression correlates with poor prognosis in thymoma patients |
|
https://doi.org/10.18632/oncotarget.24645
|
| 16665-16677 |
|
| Chemerin induces endothelial cell inflammation: activation of nuclear factorkappa beta and monocyteendothelial adhesion |
|
https://doi.org/10.18632/oncotarget.24659
|
| 16678-16690 |
|
| Prognostic value of circulating microRNAs in upper tract urinary carcinoma |
|
https://doi.org/10.18632/oncotarget.24672
|
| 16691-16700 |
|
| Antiapoptotic BCL2 proteins determine sorafenib/regorafenib resistance and BH3mimetic efficacy in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.24673
|
| 16701-16717 |
|
| Glycogen debranching enzyme AGL is a novel regulator of nonsmall cell lung cancer growth |
|
https://doi.org/10.18632/oncotarget.24676
|
| 16718-16730 |
|
| High competing risks minimize realworld utility of adjuvant targeted therapy in renal cell carcinoma: a populationbased analysis |
|
https://doi.org/10.18632/oncotarget.24675
|
| 16731-16743 |
|
| Anticancerous effect of ciskhellactone from Angelica amurensis through the induction of three programmed cell deaths |
|
https://doi.org/10.18632/oncotarget.24686
|
| 16744-16757 |
|
| Application of a doublecolour upconversion nanofluorescent probe for targeted imaging of mantle cell lymphoma |
|
https://doi.org/10.18632/oncotarget.23860
|
| 16758-16774 |
|
| Canonical NFκB signaling in myeloid cells promotes lung metastasis in a mouse breast cancer model |
|
https://doi.org/10.18632/oncotarget.24697
|
| 16775-16791 |
|
| STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral Tcell lymphoma |
|
https://doi.org/10.18632/oncotarget.24698
|
| 16792-16806 |
|
| Novel drugresistance mechanisms of pemetrexedtreated nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.24704
|
| 16807-16821 |
|
| Prognostic value of early 18FFDG PET scanning evaluation in immunocompetent primary CNS lymphoma patients |
|
https://doi.org/10.18632/oncotarget.24706
|
| 16822-16831 |
|
| Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenibsensitive and resistant melanomas |
|
https://doi.org/10.18632/oncotarget.24709
|
| 16832-16846 |
|
| Cisplatin liposome and 6amino nicotinamide combination to overcome drug resistance in ovarian cancer cells |
|
https://doi.org/10.18632/oncotarget.24708
|
| 16847-16860 |
|
| The JmjN domain as a dimerization interface and a targeted inhibitor of KDM4 demethylase activity |
|
https://doi.org/10.18632/oncotarget.24717
|
| 16861-16882 |
|
| Incidence and risk factors for venous thromboembolism in patients with pretreated advanced pancreatic carcinoma |
|
https://doi.org/10.18632/oncotarget.24721
|
| 16883-16890 |
|
| ATM/RB1 mutations predict shorter overall survival in urothelial cancer |
|
https://doi.org/10.18632/oncotarget.24738
|
| 16891-16898 |
|
| Competitive docking model for prediction of the human nicotinic acetylcholine receptor α7 binding of tobacco constituents |
|
https://doi.org/10.18632/oncotarget.24458
|
| 16899-16916 |
|
| A novel dual panPIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.24747
|
| 16917-16931 |
|
| Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms |
|
https://doi.org/10.18632/oncotarget.24524
|
| 16932-16950 |
|
| Testosterone metabolites inhibit proliferation of castration and therapyresistant prostate cancer |
|
https://doi.org/10.18632/oncotarget.24763
|
| 16951-16961 |
|
| Synthesis and anticancer activity of the derivatives of marine compound rhizochalin in castration resistant prostate cancer |
|
https://doi.org/10.18632/oncotarget.24764
|
| 16962-16973 |
|
| Blood freecirculating DNA testing by highly sensitive methylation assay to diagnose colorectal neoplasias |
|
https://doi.org/10.18632/oncotarget.24768
|
| 16974-16987 |
|
| Nonsecretion of AFP and neutrophil lymphocyte ratio as predictors for survival in hepatocellular carcinoma patients treated with sorafenib: a large UK cohort |
|
https://doi.org/10.18632/oncotarget.24769
|
| 16988-16995 |
|
| Small molecule CXCR4 antagonists block the HIV1 Nef/CXCR4 axis and selectively initiate the apoptotic program in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.24580
|
| 16996-17013 |
|
| Molecular signatures associated with tumorspecific immune response in melanoma patients treated with dendritic cellbased immunotherapy |
|
https://doi.org/10.18632/oncotarget.24795
|
| 17014-17027 |
|
| CTCFKDM4A complex correlates with histone modifications that negatively regulate CHD5 gene expression in cancer cell lines |
|
https://doi.org/10.18632/oncotarget.24798
|
| 17028-17042 |
|
| Mutation analysis of the EGFR pathway genes EGFR RAS PIK3CA BRAF and AKT1 in salivary gland adenoid cystic carcinoma |
|
https://doi.org/10.18632/oncotarget.24818
|
| 17043-17055 |
|
| CDX2 expression is concordant between primary colorectal cancer lesions and corresponding liver metastases independent of chemotherapy: a singlecenter retrospective study in Japan |
|
https://doi.org/10.18632/oncotarget.24842
|
| 17056-17065 |
|
| Ferric citrate and ferric EDTA but not ferrous sulfate drive amphiregulinmediated activation of the MAP kinase ERK in gut epithelial cancer cells |
|
https://doi.org/10.18632/oncotarget.24899
|
| 17066-17077 |
|
| Copy number changes at 8p1112 predict adverse clinical outcome and chemo and radiotherapy response in breast cancer |
|
https://doi.org/10.18632/oncotarget.24904
|
| 17078-17092 |
|
| Racial differences in endometrial cancer molecular portraits in The Cancer Genome Atlas |
|
https://doi.org/10.18632/oncotarget.24907
|
| 17093-17103 |
|
| Development of a quantitative pharmacodynamic assay for apoptosis in fixed tumor tissue and its application in distinguishing cytotoxic drug−induced DNA double strand breaks from DNA double strand breaks associated with apoptosis |
|
https://doi.org/10.18632/oncotarget.24936
|
| 17104-17116 |
|
| 89Zrnimotuzumab for immunoPET imaging of epidermal growth factor receptor I |
|
https://doi.org/10.18632/oncotarget.24965
|
| 17117-17132 |
|
| Age at menarche and risks of gestational diabetes mellitus: a metaanalysis of prospective studies |
|
https://doi.org/10.18632/oncotarget.23658
|
| 17133-17140 |
|
| Systematic review and metaanalysis of the prognostic significance of microRNAs in cervical cancer |
|
https://doi.org/10.18632/oncotarget.23839
|
| 17141-17148 |
Clinical Research Papers
|
| Relationship between hospital volume and shortterm outcomes: a nationwide populationbased study including 75280 rectal cancer surgical procedures |
|
https://doi.org/10.18632/oncotarget.24699
|
| 17149-17159 |
|
| Pharmacogeneticsbased areaundercurve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.24715
|
| 17160-17170 |
Reviews
|
| Head and neck squamous cell carcinoma and its correlation with human papillomavirus in people living with HIV: a systematic review |
|
https://doi.org/10.18632/oncotarget.24660
|
| 17171-17180 |
|
| Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging |
|
https://doi.org/10.18632/oncotarget.24729
|
| 17181-17198 |
|
| Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments |
|
https://doi.org/10.18632/oncotarget.24762
|
| 17199-17209 |
|
| Leptin signaling axis specifically associates with clinical prognosis and is multifunctional in regulating cancer progression |
|
https://doi.org/10.18632/oncotarget.24966
|
| 17210-17219 |
|
| Influence of physical exercise on microRNAs in skeletal muscle regeneration aging and diseases |
|
https://doi.org/10.18632/oncotarget.24991
|
| 17220-17237 |
|
| Cardiovascular diseaserelated miRNAs expression: potential role as biomarkers and effects of training exercise |
|
https://doi.org/10.18632/oncotarget.24428
|
| 17238-17254 |
Corrections
|
| Correction: The dual PI3K/mTOR inhibitor dactolisib elicits antitumor activity in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.25063
|
| 17255-17255 |
|
| Correction: Evaluation of tenascinC by tenatumomab in Tcell nonHodgkin lymphomas identifies a new target for radioimmunotherapy |
|
https://doi.org/10.18632/oncotarget.25064
|
| 17256-17256 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
